The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I dose-escalation study of MCLA-158, a first-in-class bispecific antibody targeting EGFR and LGR5, in metastatic colorectal cancer (CRC).
 
Guillem Argiles
No Relationships to Disclose
 
Christiane Jungels
No Relationships to Disclose
 
Rocio Garcia-Carbonero
No Relationships to Disclose
 
Marc Diez Garcia
No Relationships to Disclose
 
Johanna C. Bendell
No Relationships to Disclose
 
Josep Tabernero
No Relationships to Disclose
 
Mohamed Bekradda
No Relationships to Disclose
 
Jeroen Lammerts van Bueren
No Relationships to Disclose
 
Kees Bol
No Relationships to Disclose
 
Viktoriya Stalbovskaya
No Relationships to Disclose
 
Szabolcs Fatrai
No Relationships to Disclose
 
Arjen Brinkman
No Relationships to Disclose
 
Ernesto Wasserman
No Relationships to Disclose
 
Antoine Hollebecque
No Relationships to Disclose